Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Accumulated Expenses (2011 - 2026)

Palatin Technologies' (PTN) quarterly Accumulated Expenses came in at $653397.0 in Q1 2026, up 29.01% YoY from $506460.0 in Q1 2025, and down 0.98% on a QoQ basis from $659841.0 in Q4 2025.

Palatin Technologies (PTN) Accumulated Expenses (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 15 years of Accumulated Expenses data on file, last reported at $653397.0 in Q1 2026.

  • Quarterly Accumulated Expenses rose 29.01% year-over-year to $653397.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $653397.0 (up 29.01% YoY) and the FY2025 annual result came in at $881412.0, down 78.94% from the prior year.
  • Accumulated Expenses fell to $653397.0 in Q1 2026, from $659841.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $7.2 million in Q3 2023 to a low of $506460.0 in Q1 2025.
  • A 5-year average of $3.7 million and a median of $4.2 million in 2024 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2023 — Accumulated Expenses soared 74.34% — and 2025, when it plunged 85.13%.
  • Tracing PTN's Accumulated Expenses over 5 years: stood at $6.1 million in 2022, then dropped by 7.44% to $5.6 million in 2023, then plunged by 70.6% to $1.7 million in 2024, then tumbled by 60.03% to $659841.0 in 2025, then decreased by 0.98% to $653397.0 in 2026.
  • The last three Accumulated Expenses figures came in at $653397.0 (Q1 2026), $659841.0 (Q4 2025), and $679966.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Palatin Technologies 40.37 Mn 40.37 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 653,397.00
Dec 31, 2025 659,841.00
Sep 30, 2025 679,966.00
Jun 30, 2025 881,412.00
Mar 31, 2025 506,460.00
Dec 31, 2024 1.65 Mn
Sep 30, 2024 4.57 Mn
Jun 30, 2024 4.19 Mn
Mar 31, 2024 2.36 Mn
Dec 31, 2023 5.61 Mn
Sep 30, 2023 7.15 Mn
Jun 30, 2023 6.51 Mn
Mar 31, 2023 5.54 Mn
Dec 31, 2022 6.07 Mn
Sep 30, 2022 6.12 Mn
Jun 30, 2022 6.88 Mn
Mar 31, 2022 3.18 Mn
Dec 31, 2021 6.18 Mn
Sep 30, 2021 4.99 Mn
Jun 30, 2021 5.80 Mn